PRMT7 Preserves Satellite Cell Regenerative Capacity  by Blanc, Roméo Sébastien et al.
ArticlePRMT7 Preserves Satellite Cell Regenerative
CapacityGraphical AbstractHighlightsd PRMT7 is required for muscle stem cell self-renewal and
regenerative capacity in vivo
d PRMT7 deletion causes senescence of activated muscle
stem cells
d This entry into senescence is associated with persistent
expression of p21Blanc et al., 2016, Cell Reports 14, 1528–1539
February 16, 2016 ª2016 The Authors
http://dx.doi.org/10.1016/j.celrep.2016.01.022Authors
Rome´o Se´bastien Blanc, Gillian Vogel,
Taiping Chen, Colin Crist,
Ste´phane Richard
Correspondence
colin.crist@mcgill.ca (C.C.),
stephane.richard@mcgill.ca (S.R.)
In Brief
Decline of muscle stem cell function is
associated with both intrinsic and
extrinsic factors. Blanc et al. show that
the protein arginine methyltransferase
PRMT7 regulates the p21/DNMT3b axis in
muscle stem cells to preserve their
intrinsic capacity to self-renew and to
fully regenerate muscles in adult mice.Accession NumbersGSE75993
Cell Reports
ArticlePRMT7 Preserves Satellite Cell
Regenerative Capacity
Rome´o Se´bastien Blanc,1,2 Gillian Vogel,1,2 Taiping Chen,3 Colin Crist,1,4,* and Ste´phane Richard1,2,*
1Terry Fox Molecular Oncology Group and Bloomfield Center for Research on Aging, Lady Davis Institute for Medical Research, Sir Mortimer
B. Davis Jewish General Hospital, Montre´al, QC H3T 1E2, Canada
2Departments of Oncology and Medicine, McGill University, Montre´al, QC H3T 1E2, Canada
3Department of Molecular Carcinogenesis and Center for Cancer Epigenetics, The University of TexasMD Anderson Cancer Center, Science
Park, Smithville, TX 78957, USA
4Department of Human Genetics, McGill University, Montre´al, QC H3T 1E2, Canada
*Correspondence: colin.crist@mcgill.ca (C.C.), stephane.richard@mcgill.ca (S.R.)
http://dx.doi.org/10.1016/j.celrep.2016.01.022
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARY
Regeneration of skeletal muscle requires the con-
tinued presence of quiescent muscle stem cells
(satellite cells), which become activated in response
to injury. Here, we report that whole-body protein
arginine methyltransferase PRMT7/ adult mice
and mice conditionally lacking PRMT7 in satellite
cells using Pax7-CreERT2 both display a significant
reduction in satellite cell function, leading to defects
in regenerative capacity upon muscle injury. We
show that PRMT7 is preferentially expressed in
activated satellite cells and, interestingly, PRMT7-
deficient satellite cells undergo cell-cycle arrest
and premature cellular senescence. These defects
underlie poor satellite cell stem cell capacity to
regenerate muscle and self-renew after injury.
PRMT7-deficient satellite cells express elevated
levels of the CDK inhibitor p21CIP1 and low levels
of its repressor, DNMT3b. Restoration of DNMT3b
in PRMT7-deficient cells rescues PRMT7-mediated
senescence. Our findings define PRMT7 as a regu-
lator of the DNMT3b/p21 axis required to maintain
muscle stem cell regenerative capacity.
INTRODUCTION
Robust tissue regeneration requires the presence of somatic
stem cells capable of differentiation and self-renewal, such
that they are present throughout the lifetime of the individual.
These properties are illustrated by the activity of the quiescent
muscle stem cell, named the satellite cell for its normal anatom-
ical position underneath the basal lamina of the myofiber, which
is the sole cell responsible for regeneration of muscle (Lepper
et al., 2011; Sambasivan et al., 2011). Quiescent satellite cells
are marked by transcription factors of the paired homeodomain
family Pax7, and in a subset of muscles, Pax3. Following injury,
satellite cells re-enter the cell cycle and activate the myogenic
program, marked by the expression of myogenic regulatory fac-1528 Cell Reports 14, 1528–1539, February 16, 2016 ª2016 The Authtors Myf5, MyoD, and Myogenin, as they differentiate to repair
muscle fibers.
A critical role for epigenetic regulation of satellite cell function
is emerging as methyltransferase EZH2 and DNMT3b were
found to be necessary to repress Pax7 and Notch1 during satel-
lite cell activation and differentiation (Acharyya et al., 2010; Pal-
acios et al., 2010). Maintenance of satellite cell function is
directly dependent on histone modifications, including a switch
between H3K4 and H3K27 methylation, such that the epigenetic
mark H3K27me3 can accumulate and spread with age in quies-
cent satellite cells (Liu et al., 2013).
Satellite cell aging and the associated functional decline have
previously been demonstrated. Satellite cells enter senescence
with age driven by the accumulation of DNA damage (Sousa-
Victor et al., 2014). The CDK inhibitors p16 and p21CIP1 (p21),
critical modulators of senescence, were identified along with
p38a to induce a senescent state and a decrease of the self-
renewal capacity, respectively, leading ultimately to the inca-
pacity of the satellite cells to repair skeletal muscles (Bernet
et al., 2014; Cosgrove et al., 2014). Despite the identification of
these well-characterized senescence-related protein markers
in geriatric mice, the underlying signaling and epigenetic mech-
anisms leading to satellite cell aging are still poorly understood.
Questions regarding satellite cell function in muscle aging
remain, since the inducible depletion of the satellite cell pool
does not accelerate sarcopenia but may participate in muscle
fibrosis (Fry et al., 2015). Moreover, the molecular mechanisms
ensuring the integrity of the satellite cell pool during aging are
unknown.
Protein arginine methylation is a common post-translational
modification carried out by the nine members of the protein argi-
nine methyltransferase (PRMT) family (Bedford and Richard,
2005). PRMTs have been classified in three types according to
their catalytic activities: type I (PRMT1, 2, 3, 4, 6, and 8) and
type II enzymes (PRMT5 and 9) carry out the formation of mono-
methylarginine as an intermediate before the establishment of
asymmetric or symmetric arginine methylation, respectively
(Yang and Bedford, 2013; Yang et al., 2015); PRMT7 has been
shown to be a type III enzyme able to catalyze only the formation
of stablemonomethylarginines, and thus far, histones are its only
known substrates (Feng et al., 2013; Zurita-Lopez et al., 2012).ors
Arginine methylation has been shown to play roles in transcrip-
tion, DNA repair, signal transduction, and other pathways (Than-
dapani et al., 2013; Yang and Bedford, 2013). The importance
of arginine methylation in satellite cell function is emerging.
CARM1/PRMT4 was identified as a crucial player for both the
maintenance of the satellite cell pool and their differentiation
by regulating asymmetric division via Pax7 methylation (Kawabe
et al., 2012). Recently, PRMT5was shown to be essential for sat-
ellite cell proliferation by silencing of the cell-cycle inhibitor p21
(Zhang et al., 2015); however, the molecular details of this regu-
lation were not fully characterized.
To define the physiological function of PRMT7, we generated a
conditional knockout allele. Interestingly, mice with whole-body
knockout of PRMT7 were viable, and 8-month-old mice had
significantly less skeletal muscle and increased epididymal fat.
Investigation of PRMT7 in satellite cell function revealed that it
is required for viability, proliferation and their subsequent differ-
entiation. Specifically, depletion of PRMT7 solely in Pax7+ satel-
lite cells using an inducible Pax7-CreERT2 (Murphy et al., 2011)
recapitulated the perturbed satellite cell functions. Furthermore,
we show that PRMT7 epigenetically influences the expression of
p21 via the transcriptional regulation of DNA methyltransferase
DNMT3b. These findings define PRMT7 as a regulator of the
DNMT3b/p21 axis required to maintain muscle stem cell regen-
erative capacity.
RESULTS
Adult PRMT7-Deficient Mice Have Increased Obesity
and Decreased Muscle Mass
To investigate the physiological role of PRMT7, we generated a
knockout allele where exon 4 was flanked by LoxP sites for
Cre recombination (Figures S1A and S1B). The mice were viable,
with frequent postnatal deaths on a mixed C57BL6/129sv
background, and a similar observation was reported recently
(Ying et al., 2015). However, this mortality was significantly
decreased when we backcrossed with wild-type (WT) C57BL6
mice for more than six generations. Immunoblotting confirmed
the generation of a PRMT7 null allele, as the protein was absent
in mouse embryonic fibroblasts (MEFs) and adult skeletal
muscle (Figure 1A). PRMT7/ female and male mice were
smaller at birth than their WT littermates (Figure S1C), with no
other overt phenotype. Although PRMT7/ males and females
statistically weighed less at 3 months of age compared to WT lit-
termates, this difference was not observed at 8 months of age
(Figures S1C and S1D). Interestingly, necropsy of 8-month-old
PRMT7/ mice revealed significantly more epididymal fat
and less skeletal muscle mass, as assessed by the tibialis ante-
rior (TA) muscle, while the weight of the kidneys, spleen, heart,
and other fat pads including retroperitoneal and subcutaneous
fat were similar (Figure 1B). These findings suggest that
PRMT7/ mice have defects in maintaining their skeletal mus-
cle mass and have increased adipogenesis.
Myogenic Differentiation Is Delayed in the Absence of
PRMT7
To examine the role of PRMT7 during the myogenic program, we
first investigated the expression of PRMT7 during the culturing ofCell Rsatellite cells purified from skeletal muscle by magnetic cell sep-
aration. We observed that PRMT7 was predominantly nuclear
and co-stained with Pax7 in activated satellite cells after
3 days of culture (Figure 1C), but the mRNA levels were unde-
tectable in freshly isolated satellite cells (day 0; Figure 1D). More-
over, satellite cell cultures indicated that PRMT7 mRNA was
elevated, and these levels were maintained during differentia-
tion, similar to MyoD expression (Figure 1D).
We further investigated the differentiation of satellite cells in
single muscle fibers freshly isolated from the extensor digitorum
longus (EDL) muscle of 8- to 10-week-old WT and PRMT7/
mice. The fibers were fixed immediately (0 hr) or cultured for
24 hr and 48 hr prior to fixation and stained with anti-Pax7 and
anti-MyoD antibodies. Pax7+/MyoD denotes satellite cells
that have not yet engaged the myogenic program, while
Pax7+/MyoD+ and Pax7/MyoD+ represent satellite cells un-
dergoing activation or differentiation, respectively (Figure 1E).
After 24 hr of culture, most of the satellite cells isolated from
WTmice were activated and20% of the population was begin-
ning to differentiate (Figures 1E and 1F). In the PRMT7/ EDL
fibers, satellite cells were also activated after 24 hr, as assessed
by MyoD expression. However, while the majority of WT satellite
cells were differentiating (Pax7/MyoD+) at 48 hr, PRMT7/
satellite cells exhibited a differentiation defect, as they main-
tained Pax7 expression at 48 hr of culturing (Figure 1F).
Transcriptome Analysis Reveals a Role in Cell-Cycle
Regulation and Cellular Senescence
RNA sequencing was utilized to profile the expressed transcripts
using RNA isolated from the skeletal muscle from WT and
PRMT7/ mice (Tables S1, S2, and S3; Figure S2). In the
absence of PRMT7, 458 genes were found upregulated and
142 downregulated (log ratio > 0.95; p > 0.05). The data were
analyzed using Ingenuity Pathway Analysis (IPA) where 727
regulated genes (log ratio > 0.95) generated a total of 23 canon-
ical pathways (log [p] > 1.5). Among five groupswith a Z score >
1.5 (Figure S2B), four were cell-cycle pathways. Clustering of
diseases and major molecular and cellular function annotation
(Table S2) further linked PRMT7 as a cell-cycle regulator with
134 unique genes. Moreover, 130 distinctive genes involved in
skeletal and muscular disorders showed altered expression in
the absence of PRMT7 (Table S2). Upstream analysis identified
30 upstream regulators (bias-corrected Z score > ±1.5; p >
0.05), including Tp53, Rb1, Dnmt3b, Cdkn1a, Cdkn2a, and
Pten (Tables S1 and S3).
PRMT7 Depletion Triggers Premature Senescence of
Satellite Cells
We next confirmed the expression of certain cell-cycle regula-
tors by immunoblotting. We observed elevated p21 protein
levels in PRMT7-deficient activated satellite cells (ASCs) isolated
from PRMT7/mice, but not satellite cells fromWTmice. Inter-
estingly, increased p21 was not observed in non-satellite cells
isolated from PRMT7/ mice (NSC; Figure 2A). It has been
shown that persistent expression of the gene for p21, Cdkn1a,
promotes aging in stem cells (Bell and Sharpless, 2007). One
key regulator ofCdkn1a gene expression is the transcription fac-
tor p53 (el-Deiry et al., 1994). However, the PRMT7-mediatedeports 14, 1528–1539, February 16, 2016 ª2016 The Authors 1529
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Figure 1. PRMT7 Depletion Impairs Satellite Cell Differentiation
(A) Lysates prepared from MEFs and skeletal muscle tissue of PRMT7+/+ and PRMT7/ mice and immunoblotted with the indicated antibodies.
(B) Measurement of the weight from fat tissues, organs and TA muscle from WT and PRMT7/ mice relative to the total body mass. Numbers are reported as
mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001, Student’s t test.
(C) Immunostaining of Pax7 and PRMT7 of satellite cells isolated using magnetic-activated cell sorting (MACS) purification. DAPI stain nuclei blue in merge.
(D) Transcript levels of satellite cell differentiation marker MyoD and PRMT7 from MACS-purified satellite cells immediately after isolation (quiescent) or cultured
for 3 days (activation) and 5 days (differentiation).
(E) Pax7 (green) and MyoD (red) immunostaining on single muscle fibers immediately after isolation or cultured in satellite cell media for 24 hr and 48 hr. DAPI
stains nuclei blue. Extensor digitorium longus (EDL) muscle fibers were isolated from 8- to 10-week-old WT and PRMT7/ mice.
(F) The percentage of satellite cells on total EDL fibers that are undergoing self-renewal (Pax7+/MyoD; QCS), activation (Pax7+/MyoD+; ASC), and differentiation
(Pax7/MyoD+). Analysis was performed using pooled data from n = 3 PRMT7+/+ (left) and PRMT7/mice (right), with 30 fibers per condition. Values are reported
as mean ± SD.
See also Figure S1.high levels of p21 are likely p53 independent, as the levels of p53
did not change in the absence of PRMT7 (Figure 2A). RNA-
sequencing (RNA-seq) upstream analysis showed that DNMT3b
is predicted to be inhibited in absence of PRMT7, but its mRNA
levels were not altered in whole muscle RNA-seq (Tables S1 and
S3). DNMT3b is a known regulator of p21 expression by methyl-1530 Cell Reports 14, 1528–1539, February 16, 2016 ª2016 The Authating the promoter of Cdkn1a, which decreases its expression
levels (So et al., 2011). Interestingly, DNMT3b protein levels
were inversely proportional with p21 levels in satellite cells of
PRMT7/ mice (Figure 2A). Furthermore, we observed that
elevated PRMT7 and DNMT3b protein levels correlated during
satellite cell differentiation (Figure 2B). These findings suggestors
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Figure 2. Loss of PRMT7 Induces Premature Senescence in Activated Satellite Cells
(A) Lysates prepared from MACS-isolated satellite cells from WT and PRMT7/mice were immunoblotted with the indicated antibodies. The non-satellite cells
consisted of the remaining cells after the MACS isolation.
(B) PRMT7, p53, p21, and DNMT3b protein levels during satellite cell differentiation from MACS-purified satellite cells immediately after isolation (quiescent;
QSC), or cultured in satellite cell media for 3 days (activated; ASC) and 5 days (differentiating; DSC). The non-satellite cells (NSC) consisted of the remaining cells
after MACS isolation. Ponceau shows total protein. The molecular mass markers are denotes on the left in kDa.
(legend continued on next page)
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that PRMT7 regulates the expression of DNMT3b during muscle
differentiation. Elevated p21 expression is a known marker of
cellular senescence (Wang et al., 2000). We observed 30% of
the satellite cells isolated from 8-month-old PRMT7/ mice
contained senescence associated b-galactosidase (SA-b-gal)
activity (Figure 2C, top). To ask whether these changes were
autonomous to the satellite cell, we repeated experiments in
8-month-old PRMT7FL/FL; Pax7CreERT2/+ mice treated with 4-hy-
droxytamoxifen (OHT). We identified 22% of satellite cells
isolated from OHT-treated PRMT7FL/FL; Pax7CreERT2/+ mice as
senescent, while this activity was essentially undetectable in
WT satellite cells (Figure 2C). Interestingly, we also detected an
increase in the number of SA-b-gal-activity-positive cells in car-
diotoxin (Ctx)-injured TA muscles from either PRMT7/mice or
OHT-treated PRMT7FL/FL; Pax7CreERT2/+mice, which was absent
in WT mice (Figure 2D).
Conditional inactivation of PRMT7 in satellite cells of 8-month-
old mice also led to decreased protein levels of DNMT3b
and increased levels of p21 (Figure 2E). We also observed
the decreased Dnmt3b expression in OHT-treated PRMT7FL/FL;
Pax7CreERT2/+ activated satellite cells, as represented by the sig-
nificant diminutionofmRNA levels (Figure2F). Thesefindingssug-
gest that PRMT7 regulates DNMT3b expression in satellite cells.
CpG Islands of Cdkn1a Promoter Are Hypomethylated
We next investigated the mechanism by which PRMT7 regulates
p21 expression using the C2C12 myoblast cell line. PRMT7
knockdown in C2C12 cells resulted in differentiation defects
indicated by low fusion and alignment of myotubes that are nor-
mally observed after culturing for 3 days in differentiation me-
dium (Figures S3A and S3B). We also established that small
interfering RNA (siRNA)-mediated knockdown of PRMT7 in
proliferating C2C12 cells led to cell growth arrest (Figure S3C).
We noted that 50% of the siPRMT7-transfected C2C12 cells
underwent cellular senescence, whereas virtually none of the
control cells (siLuc) displayed this phenotype (Figure 3A). Immu-
noblotting confirmed that PRMT7-knockdown cells expressed
elevated p21 and downregulated DNMT3b (Figure 3B), with little
to no change in p53 expression, consistent with what was
observed in PRMT7/ satellite cells. Given the low levels of
DNMT3b expressed in PRMT7-deficient cells, we tested the
possibility that the CpG islands at the Cdkn1a promoter might
be hypomethylated, leading to increased p21 gene expression.
To do so, we performed bisulfite sequencing on sites containing
CpG islands pre-identified in silico. Among them, twoCpGswere
found to be significantly (50% compared to 10%; p = 0.018)
hypomethylated in siPRMT7 C2C12 cells (Figure 3C). The
methylation status of the Cdkn1a promoter was later confirmed(C) Representative images and quantification of SA-b-Gal staining from WT a
PRMT7FL/FL; Pax7CreERT2/+ satellite cells (bottom). Quantification is noted to the r
cells ± SD from n = 3 mice per genotype with cells > 200.
(D) Lysates prepared from MACS-isolated satellite cells from PRMT7FL/FL;  and
with the indicated antibodies.
(E) qRT-PCR analysis of mRNA levels of Prmt7 and Dnmt3b isolated from PRMT
genotype.
(F) SA-b-Gal staining of transverse sections of the TA muscle from WT and PRMT
panel) extracted 21 days after Ctx injury. Scale bars represent 50 mm.
*p < 0.05, **p < 0.01, and ***p < 0.001, Student’s t test. See also Figure S2 and T
1532 Cell Reports 14, 1528–1539, February 16, 2016 ª2016 The Authusing methyl-specific primers. In the absence of PRMT7, quan-
tification of the methyl-specific PCR supports the notion that
CpG1 and CpG2 are hypomethylated, while control siLuc cells
had a significantly larger ratio of methylated CpG1 and CpG2
(Figure 3D). These findings suggest that PRMT7 indirectly regu-
lates DNA methylation by regulating the expression of DNMT3b.
Restoring DNMT3b Expression Rescues PRMT7-
Induced Premature Senescence
To establish that DNMT3b is a key regulator of Cdkn1a expres-
sion in PRMT7-knockdown cells, we transiently transfected
myc-epitope tagged human DNMT3b in siPRMT7 C2C12 cells.
The cells were subsequently assessed for cellular senescence
by staining for SA-b-gal. Indeed, the re-expression of DNMT3b
in siPRMT7 C2C12 cells rescued the senescence by 65%
(33% versus 11%; p < 0.001, Figure 4A). Immunoblotting
and qRT-PCR of p21 and myc-DNMT3b confirmed that restored
DNMT3b expression downregulated both p21 mRNA and pro-
tein levels (Figures 4B and 4C). Anti-DNMT3b antibody detected
endogenous mouse DNMT3b, but not the myc-human DNMT3b
protein. Decreased levels of DNMT3b observed in siPRMT7-
transfected cells (Figure 4B, lane 2) were restored in myc-
DNMT3b-transfected cells (Figure 4B, lanes 3 and 4). Moreover,
endogenous mouse DNMT3b transcript levels decreased signif-
icantly in the absence of PRMT7 (Figure 4C). These findings sug-
gest that PRMT7 regulates the expression of DNMT3b, which
regulates the p21 expression by DNA methylation. To further
confirm that DNMT3b is responsible for the DNAmethylation sta-
tus of CpG1 andCpG2 ofCdkn1a, we performedmethyl-specific
PCR using modified DNA from C2C12 cells transfected with
myc-DNMT3b and treated with siLuc or siPRMT7. Quantification
of the methyl-specific PCR showed that rescuing DNMT3b
expression restores the methylation status of CpG1 and CpG2
within theCdkn1a promoter in siPRMT7 C2C12 cells (Figure 4D).
Together, these data provide evidence that PRMT7 regulates
p21 expression through DNA methylation by DNMT3b.
PRMT7 Depletion Decreases H4R3me2s at Dnmt3b and
Cdkn1a Promoter
PRMT7 is known to methylate arginines resulting in monomethy-
larginines, however, no physiological substrates have been iden-
tified other than histoneswith a preference for histone H2B (Feng
et al., 2013). Previous studies have reported that PRMT7-defi-
cient cells harbor less symmetrical dimethylation of H3R2 (Mi-
gliori et al., 2012) and H4R3 (Karkhanis et al., 2012; Ying et al.,
2015), however, the mechanism as to how this hypomethylation
occurs is unknown. It was initially thought that PRMT7 primes the
sites for the subsequent methylation by type II enzymes PRMT5nd PRMT7/ satellite cells (top) and PRMT7FL/FL;  (denotes no Cre) and
ight. The numbers represent the mean of the percentage of SA-b-Gal positive
PRMT7FL/FL; Pax7CreERT2/+ mice treated 5 days with OHT were immunoblotted
7FL/FL;  and PRMT7FL/FL; Pax7CreERT2/+ isolated satellite cells. n = 5 mice per
7/ mice (left) and PRMT7FL/FL;  and PRMT7FL/FL; Pax7CreERT2/+ mice (right
ables S1, S2, and S3.
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Figure 3. PRMT7 Knockdown in Myoblasts
Induces Hypomethylation of the Cdkn1a
Promoter and Rapid Entry into Senescence
(A) Images and quantification from SA-b-Gal
staining of C2C12 transfected cells with siLuc (left)
and siPRMT7 (right). Cells were transfected twice
with siRNAs prior to fixation and staining. Scale
bar, 10 mm.
(B) Immunoblots of PRMT7, p53, p21, DNMT3b,
and Tubulin from C2C12 cells transfected with si-
Luc or siPRMT7. Tubulin serves as a loading
control. Molecular mass markers are shown on the
left in kDa.
(C) Bisulfite sequencing of DNA from C2C12 cells
transfected with siLuc or siPRMT7 treated with
EpiTech Bisulfite kit (QIAGEN). Rows are derived
from the sequence analysis of at least 10 individual
cloned PCR products of the Cdkn1a gene
following bisulfite modification. A circle reports the
methylation status of a single CpG site (white,
unmethylated; black, methylated).
(D) Gel quantification of methyl-specific PCR using
primers designed according to the bisulfite
sequencing analysis to evaluate the methylation
status of CpG1 and CpG2 islands as follows: un-
methylated (Unmeth), methylated only at CpG1
(CpG1-me), methylated only at CpG2 (CpG2-me),
or methylated at both CpGs (CpG1-me/CpG2-
me). Primers were confirmed for specificity using
DNA from analyzed clones known to be un-
methylated or methylated at the CpG1 and CpG2.
Quantification was performed using ImageJ. The
numbers represent the mean relative to the un-
methylated siLuc cells ± SEM from at least three
experiments in biological triplicate.
*p < 0.05, **p < 0.01, and ***p < 0.001, Student’s t
test (A) or Fisher exact test (C) ANOVA (one way)
(D). See also Figures S3 and S4.and PRMT9, however, H3R2 and H4R3 sequences are not
favored PRMT7 methylation sites (Feng et al., 2013). Neverthe-
less, we monitored the symmetrical methylation of H4R3 at the
Dnmt3b andCdnk1a promoters using chromatin immunoprecip-
itation (ChIP) assays. In both cases H4R3me2s was decreased in
siPRMT7 C2C12 cells (Figure S4A). We monitored the levels of
the activating mark, H3K4me3, and consistent with silencing of
Dnmt3b and activation of Cdkn1a expression in PRMT7-defi-
cient cells, H3K4me3 was decreased on the Dnmt3b promoter,
while increased at the Cdnk1a promoter (Figure S4B). We at-
tempted to ChIP PRMT7, but our in-house anti-PRMT7 and the
commercial antibody (Novus, catalog # NBP2-19939) were not
of ChIP quality (not shown). These findings show that PRMT7
expression regulates the epigenetic changes on both the
Dnmt3b and Cdnk1a promoters.
The Absence of PRMT7 in Satellite Cells Results in
Muscle Regeneration Defects
We showed PRMT7 deficiency leads to a decrease in muscle
mass in 8-month-old mice, a delay in activation of the myogenic
program and premature satellite cell senescence. Satellite cell
stem cell capacity to regenerate muscle requires that they not
only activate the myogenic program to differentiate and repairCell Rmuscle but also self-renew, such that they return to their normal
positionunderneath thebasal laminaof themyofiber.We therefore
asked whether PRMT7-deficient mice also exhibit a regeneration
defect in vivo, comparing youngmice to adultmice.We examined
the regeneration of TAmuscles 21days after Ctx injury. The size of
centrally nucleated fibers (CNFs) from 2-month-old PRMT7/
mice was slightly increased compared to the controls (Figure 5A),
suggesting that muscle regeneration was similar in youngWT and
PRMT7/mice.Wenext injuredTAmuscles of 8-month-oldmice
and observed that the size of the CNFs was strikingly decreased
compared to WTmice (Figure 5B). In contrast, uninjured muscles
from 8-month-old PRMT7/ and WT mice did not show any
obvious structural defects (Figure S5A). These results suggest
that PRMT7 is required for satellite cell activity to regeneratemus-
cle of adultmice.Wealso evaluated the number ofSCsbefore and
after injury by intramuscular injection of Ctx treatment in 8-month-
oldmice.BeforeCtx injury, thenumberof satellite cellswasslightly
decreased in PRMT7/mice compared toWTmice (FiguresS5B
andS5C); however, 21daysafterCtx injury, the number of remain-
ing satellite cells was significantly decreased (p < 0.001) in
PRMT7/ mice (Figure 5C).
To further investigate the role of PRMT7 by the specific contri-
bution of satellite cells to regenerate muscle, we examined theeports 14, 1528–1539, February 16, 2016 ª2016 The Authors 1533
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Figure 4. DNMT3b Rescues PRMT7-Induced
Premature Senescence in Myoblasts
(A) Representative images and quantification of
SA-b-Gal staining from C2C12 cells treated with
siRNAs and then transfected with empty vector
(pcDNA3.1) or DNMT3b-Myc. Scale bar, 20 mm.
The numbers represent the mean of the percentage
of SA-b-Gal-positive cells ± SD from at least three
experiments in biological triplicate and for n < 300
cells per replicate.
(B and C) Protein (B) and mRNA (C) levels were
measured in C2C12 cells co-transfected with
siRNAs and either empty vector (pcDNA3.1) or
DNMT3b-Myc.
Note: Dnmt3b primers were specific to endoge-
nous Dnmt3b and not transfected DNMT3b-Myc.
(D) Quantification of methyl-specific PCR to assess
themethylation status of CpG1 andCpG2 identified
by bisulfite sequencing in the Cdkn1a promoter
region after DNMT3b expression rescue in C2C12
cells treated with siLuc or siPRMT7 following
bisulfite modification of the DNA. Quantification
was performed using ImageJ. The numbers repre-
sent the mean of the gel quantification relative
to the level of unmethylated DNA in control
cells ± SEM from at least three experiments in
biological triplicate.
*p < 0.05, **p < 0.01, ***p < 0.001, ANOVA (one way;
A and D) or ANOVA (two way; C).regenerative capacity of satellite cells in the muscle of OHT-
treated PRMT7FL/FL; Pax7CreERT2/+ mice (Figure 6A). Twenty-
one days after Ctx injury, regenerating myofibers of OHT-treated
PRMT7FL/FL; Pax7CreERT2/+ mice were smaller, poorly organized,
and marked by the expression of embryonic myosin heavy chain
(EMHC), indicating a delay in skeletal muscle regeneration
compared to WT mice (Figures 6B–6E). In addition, the condi-
tional deletion of PRMT7 in satellite cells resulted in a reduced
pool of Pax7-positive cells 21 days after injury, indicating a failure
of satellite cells to self-renew (Figure 6F).
DISCUSSION
Robust regeneration of skeletal muscle requires that normally
quiescent satellite cells re-enter the cell cycle to expand a popu-1534 Cell Reports 14, 1528–1539, February 16, 2016 ª2016 The Authorslation of myogenic progenitors, which
either differentiate to repair muscle or
self-renew. The molecular mechanisms
maintaining satellite cell regenerative ca-
pacity, especially as we become older,
are not well defined. In this work, we have
identified PRMT7 as a critical epigenetic
regulator preserving satellite cell capacity
to regenerate muscle in 8-month-old
mice.Wedemonstrate that upon activation
of the myogenic program, PRMT7-defi-
cient satellite cells from 8-month-old mice
enter into premature senescence and are
therefore unable to maintain the satellite
cell stem cell properties to regenerate
injured muscle and self-renew. The senescent satellite cells
from PRMT7/ and OHT-treated PRMT7FL/FL; Pax7CreERT2/+
miceexpressedhigh levelsof theCDK inhibitorp21withundetect-
able levels of DNMT3b.We also observe senescence in siPRMT7
C2C12 cells, and this senescence was bypassed by restoring
Dnmt3b expression. Our findings define PRMT7 as an epigenetic
regulator of the DNMT3b/p21 axis required to maintain muscle
stem cell regenerative capacity.
Mounting evidence implicates a loss of muscle stem cell func-
tion with age-related failure to regenerate muscle. The repeated
activationof p38a signaling following satellite cell activation leads
to a loss of self-renewal, concomitant with an increase in senes-
cence marked by the upregulation of p21 (Bernet et al., 2014;
Cosgrove et al., 2014). Our RNA-seq data reveal a role for
PRMT7 in the regulation of cell-cycle genes, since the depletion
AB
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Figure 5. PRMT7 Depletion Leads to Satellite Cell Function Decline in Adult Mice
(A and B) Transverse sections of TA muscle from 2-month-old (A) and 8-month-old (B) WT and PRMT7/mice, 21 days after Ctx injury, immunostained for Pax7
and laminin with DAPI nuclear stain. Average myofiber cross-section area of regenerating TA muscle from WT and PRMT7/ mice. n = 6 mice per genotype.
Quantification of Pax7+ satellite cells/CNFs 21 days after Ctx injury (right).
(C) Transverse sections of TAmuscle from PRMT7FL/FL; and PRMT7FL/FL; Pax7CreERT2/+mice, 21 days after Ctx injury, immunostained for Pax7 and laminin with
DAPI nuclear stain.
Averagemyofiber cross-section area of regenerating TAmuscle fromPRMT7FL/FL andPRMT7FL/FL; Pax7CreERT2/+mice, n = 5mice per genotype. Quantification of
Pax7+ satellite cells/CNFs 21 days after Ctx injury (right). Data are presented asmean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, Student’s t test. Scale bar, 50 mm.
See also Figure S5.
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of PRMT7 increases themRNA levels of several key regulators of
cell division (Cdkn1a, E2f1,Ccna2, and Ccnb1). We also observe
that after muscle injury, the number of PRMT7/ satellite cells
expressing Pax7 was dramatically reduced in 8-month-old
PRMT7/ as well as OHT-treated PRMT7FL/FL; Pax7CreERT2/+
mice, suggesting a defect in satellite cell self-renewal in vivo. Of
interest,weobserve increased senescence inPRMT7/ satellite
cells at 8 months age, similar to the observations of accelerated
satellite cell senescence in injured muscle of geriatric (age
28–32 months) mice (Sousa-Victor et al., 2014). We show that
the conditional deletion of PRMT7 in satellite cells in 8-month-
old mice leads to similar defects observed for satellite cells in
8-month-old PRMT7/ mice. We propose a model by which
PRMT7 preserves satellite cell regenerative capacity against
systemic factors that would otherwise manifest as early as age
8 months in mice. Together, these data suggest that PRMT7
prevents the expression of the pro-senescence pathway p21,
thereby maintaining the proliferative capacity of activated satel-
lite cells to ensure muscle regeneration.
PRMT7-deficient cells undergo cellular senescence; however,
it is likely that these cells also have other defects that contribute
to satellite cell dysfunction. The decision of the satellite cells to
self-renew, enter into proliferation, or return to quiescence is
driven by complex gene networks and epigenetic events (Dil-
worth and Blais, 2011). It is well established that epigenetic
programs like de novo DNA methylation govern a vast panel of
biological processes including tissue regeneration, stem cell dif-
ferentiation, and aging (Chen and Dent, 2014; Tollefsbol, 2011).
Arginine methylation is emerging as a key regulator of post-
translational modifications in this process. Pax7 methylation by
CARM1 functions as an epigenetic switch to recruit the H3K4
methyltransferase complex to regulateMyf5 expression and sat-
ellite cell asymmetric division (Kawabe et al., 2012). PRMT5 is
shown to be required for adult satellite cell proliferation (Zhang
et al., 2015). PRMT5 mediates satellite cell expansion through
the inhibition of p21 expression in a p53-independent manner
(Zhang et al., 2015). Emerging evidence suggests that PRMT5
and PRMT7 may have overlapping functions (Gonsalvez et al.,
2007; Migliori et al., 2012) but exhibit different substrate prefer-
ence (Feng et al., 2013). We show that PRMT7 regulates p21
expression via DNMT3b to regulate satellite cell expansion. As
the H4R3me2s mark was diminished on both Cdkn1a and
Dnmt3b promoters by ChIP assay, also leaves the possibility
that PRMT7 has a direct regulation of p21, especially since
rescue by myc-DNMT3b was partial. PRMT7 was reported as
a potential regulator of DNA de novo methylation during male
germline imprinting by interacting with the protein CTCF and
methylating histone H2A and H4 (Jelinic et al., 2006). Addition-
ally, PRMT5 has been shown to play a role in gene silencing
through DNA methylation regulation by recruiting DNMT3a
(Huang et al., 2011; Zhao et al., 2009). More importantly
PRMT5 is required to preserve genome integrity in germ cells
by regulating global DNA methylation (Kim et al., 2014).
PRMT7-deficient satellite cells enter senescence upon activa-
tion and express high levels of p21, whereas DNMT3b was not
present. DNMT3b was reported as a critical regulator of adult
stem cell fate decision and a key player in adult stem cell aging,
especially in hematopoietic stem cells (Challen et al., 2014;1536 Cell Reports 14, 1528–1539, February 16, 2016 ª2016 The AuthChambers et al., 2007; Kang, 2011). DNMT3b regulates stem
cell aging by inducing cellular senescence via CpG island
methylation of both p21 and p16 promoters (So et al., 2011;
Zheng et al., 2006). We hypothesize that PRMT7 regulates
DNMT3b by transcriptional control, but it is likely that post-tran-
scriptional regulation also occurs. Loss of DNMT3b would then
lead to the hypomethylation of the Cdkn1A promoter (So et al.,
2011). These epigenetic events would act as a switch to mediate
alternate satellite cell fate decision in response to muscle injury
by preventing premature cell-cycle arrest, leading cells to senes-
cence after their activation. The persistent presence and accu-
mulation of p21 in satellite cells that repeatedly activate over
time in response to muscle injury will lead to a long-term decline
of satellite cell function by causing premature senescence
instead of returning to a quiescent state.
In conclusion, we propose that PRMT7 regulates the expres-
sion of DNMT3b and subsequently p21 to maintain satellite cell
function andmuscle regeneration. These findings lead to a better
understanding of satellite cell age-related decline, making the
PRMT7 signaling pathway a potential therapeutic target against
the gradual loss of satellite cell function. Ultimately, unraveling
the mystery of the age-related decline of satellite cell function
and the associated epigenetic signature could help to restore
their regenerative capacity.
EXPERIMENTAL PROCEDURES
Animal Generation and Experiments
All animal studieswere approvedby theMcGill UniversityAnimalCareCommit-
tee. The PRMT7 conditional allele was essentially generated as previously
described (Yu et al., 2009). Briefly, sequenced plasmids containing loxP and
FRT sites flanking Prmt7 exon 4 were electroporated into 129/Sv embryonic
stem cells. Verification of homologous integration was conducted using long-
template PCR (Roche), and clones were injected into C57BL/6 blastocytes to
obtain chimeric animals. The chimeras were subsequently crossed with
C57BL/6 mice and progeny assessed for germline transmission. To remove
the neomycin resistance cassette, mice were then crossed with FLP recombi-
nase expressingmice to promote recombination between FRT sites (Jax strain
003946) resulting in a floxed allele (PRMT7FL). These mice were backcrossed
for six generations before interbreeding to obtain PRMT7FL/FL homozygotes.
To obtain a null allele, PRMT7FL mice were crossed with EIIa-Cre expressing
mice (Jax strain 003724), a ubiquitous promoter driving Cre expression to pro-
mote recombination between loxP sites within the germline. Heterozygous
mice were identified and intercrossed to obtain PRMT7/ animals. For the
generation of satellite cell-specific deletion of PRMT7, PRMT7FL/FL mice
were breed with the inducible mouse model, Pax7CreERT2/+ (Murphy et al.,
2011). To induce recombination between the loxP sites, mice were treated
with a daily dose of 4-hydroxytamoxifen (1 mg/25 g) for 5 days. Deletion of
PRMT7 was verified using mRNA analysis as well as protein analysis.
For regeneration experiments, TA muscles were injected with 10 ml solution
of 10 mMCtx. For injury studies, TA muscles were harvested and frozen in iso-
pentane cooled in liquid nitrogen and stored at 80C prior to sectioning. At
the same time, EDL muscles were extracted for EDL fiber isolation.
Tissue Culture and Transfection
Myoblast progenitor C2C12 cells were cultured in DMEM containing 20% fetal
bovine serum (FBS) (v/v) and 1% penicillin/streptomycin (v/v). Once C2C12
cells reached confluence, differentiation was induced in DMEM supplemented
with 2% FBS. All cells were incubated at 37C in 5% CO2 and humid air condi-
tions. Cells were transfected with siRNAs (Dharmacon) using Lipofectamine
RNAi MAX (Invitrogen) according to the manufacturer’s instructions. The se-
quences of PRMT7 siRNAs were (1) 50-GGACAGAAGGCCUUGGUUC-30, (2)
50-GAGCGGAGCAGGUGUUUAC-30, (3) 50-UCAGCUAUGUUGUGGAGUU-30,ors
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Figure 6. PRMT7FL/FL; Pax7creERT2/+ Mice Exhibit Regenerative Defects in Adult Mice
(A) Schematic representation of the timeframe for 4-hydroxytamoxifen (4-OHT) and cardiotoxin (Ctx) injections for regeneration analysis in PRMT7FL/FL;  and
PRMT7FL/FL; Pax7creERT2/+ mice.
(B) Regeneration analysis of TA muscles from 8-month-old PRMT7FL/FL; and PRMT7FL/FL; Pax7creERT2/+mice, 21 days after Ctx injury. Mice were injected for 5
consecutive days with 4-OHT prior to Ctx injury. Transverse sections of TA muscle immunostained for Pax7 (upper) or EMHC (lower) and laminin with DAPI
nuclear staining.
(C) Average myofiber cross-section area of regenerating TA muscles from PRMT7FL/FL; - and PRMT7FL/FL; Pax7creERT2/+ mice.
(legend continued on next page)
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and (4) 50-GUAGCUUCCUAUAGACUGA-30. A luciferase siRNA was used as
control. Plasmid DNA was transfected using Lipofectamine 2000 (Invitrogen).
Single myofibers were isolated from EDL muscles using 0.2% Collagenase
in DMEM for 60 min at 37C. Muscles were dissociated gently in pre-warmed
DMEM supplemented with 10% FBS and washed several times to remove
debris. EDL fibers were fixed immediately or at various time point after culture
in 10% formalin at room temperature (RT) for 12min and store at 4C in PBS for
experiments.
Satellite cells were isolated from freshly extracted skeletal muscles using the
Satellite Cell Isolation Kit (Miltenyi Biotec) following the manufacturer’s
protocols.
Cultured myofibers and satellite cells were incubated in satellite cell Media
(39% DMEM, 39% DMEM-F12, 20% FBS, and 2% UtroserG [Pall Biosci-
ences]) at 37C in a 5% CO2 humid atmosphere.
Tissue Processing, Immunostaining, and Microscopy
TA cryosections were fixed with formalin 10% (Sigma) at RT for 15 min and
permeabilized in cold methanol at 20C for 6 min.
Immunostaining of TA sections and EDL fibers was performed with the pri-
mary antibodies anti-Pax7 (DSHB) and anti-laminin (SIGMA) or anti-MyoD
(Santa Cruz) overnight at 4C and with the secondary antibodies Alexa Fluor
488 and 546 for 1 hr at RT. Samples were mounted in Immu-mount (Thermo
Scientific) containing DAPI (VectaShield). Images were acquired with a Zeiss
Axio Imager 2 microscope and analyzed with Axio imager software, using
the same settings for all image sets. Analysis of TA sections was performed
in a double-blind manner.
Immunoblotting and Immunoprecipitation
Cell lysates (50 mM HEPES [pH 7.4], 150 mM NaCl, and 1% Triton X-100) and
freshly added EDTA-free protease inhibitor cocktail (Roche) were immunoblot-
ted with antibodies against PRMT7, DNMT3b (Abcam), p53 (coupled to horse-
radish peroxidase; R&D Sciences), p21 (Santa Cruz Biotechnology), Myc
(Sigma), b-actin (Sigma), and b-tubulin (Sigma). Western Lightning Plus ECL
from PerkinElmer was used for chemiluminescence detection.
RNA Extraction and qPCR
RNA was extracted using TRIzol reagent (Life Technology) following the man-
ufacturer’s protocol. RNA was normalized and used for RT-PCR followed by
qPCR using EvaGreen (Bio-Rad) and the 7500 Fast Real-Time PCR system
(Applied Biosystems). Transcript levels were normalized to an average of
GAPDH, TATA binding protein (TBP), and RNAr18S and then to the control
condition.
Senescence Assays
Senescence assays were performed as described previously (Neault et al.,
2012).
Bisulfite Sequencing and Methyl-Specific PCR
Extracted DNA was converted with bisulfite treatment using EpiTect Bisulfite
Kit (QIAGEN) following the manufacturer’s protocol. Bisulfite sequencing
and methyl-specific PCR were performed as described previously (Huang
et al., 2011) using the following primers: unmethylated 50-TTTTTTTGATTTTT
GAGGTGGTTGATAG-30; CpG1me 50-TTTTTTCGATTTTTGAGGTGGTTGA
TAG-30; CpG2me 50-TTTTTTTGATTTTTGAGGCGGTTGATAG-30; CpG1me/
CpG2me 50-TTTTTTCGATTTTTGAGGCGGTTGATAG-30.
Chromatin Immunoprecipitation
Briefly, C2C12 cells were crosslinked with 1% paraformaldehyde for 10 min at
room temperature. Fixation was quenched with the addition of 0.125 M
glycine. After washing with PBS, cells were resuspended in hypotonic buffer
(50 mM Tris-HCl [pH 8.0], 85 mM KCl, and 0.5% NP-40) and passed through(D) Percentage of EMHC (embryonic myosin heavy chain)-positive (myofibers/CN
(E) Immunoblotting of PRMT7FL/FL; - and PRMT7FL/FL; Pax7creERT2/+ lysates isola
(F) Percentage of Pax7+ satellite cells/CNFs. For each analysis, n = 5 mice per g
*p < 0.05, **p < 0.01, and ***p < 0.001, Student’s t test. Scale bar, 50 mm.
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in 50 mM Tris-HCl (pH 8.0), 10 mM EDTA, and 1% SDS. Lysates were diluted
using ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA,
16.7 mM Tris-HCl [pH 8.0], and 167 mM NaCl) and incubated overnight at
4C with the following antibodies: rabbit immunoglobulin G (SC-2027 Santa
Cruz Biotech), H3 (AB1791 Abcam), H3K4me3 (AB8580 Abcam), H4
(AB10158 Abcam), and H4R3me2s (AB5823 Abcam). Protein A Sepharose
was added to the immunocomplexes and beads were washed two times in
low salt and four times with a lithium wash buffer. Elution was carried using
a buffer containing 50 mM NaHCO3 and 1% SDS. The crosslinking was
reversed with 250 mM NaCl, and eluates were boiled for 15 min. Samples
were treated with RNase A and Proteinase K. DNA was subsequently purified
using PCR purification spin columns (QIAGEN).
Statistical Tests
Statistical significance was assessed using Prism5 software via Student’s
t test (unpaired, 95% confidence interval [CI]) or ANOVA (one way or two
way, followed by Tukey post hoc test; 95% CI). Error bars are reported as
SEM or SD. p values < 0.05 were considered statistically significant (*p <
0.05, **p < 0.01, and ***p < 0.001).
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